Clinical experience of postoperative hepatic failure treatment with pig or baboon liver cross-hemodialysis with an interposed membrane.
The present study emphasizes the principle of using liver support to restore the blood ketone body ratio (acetoacetate/beta-hydroxybutyrate), which reflects the redox potential of liver mitochondria and correlates with hepatic energy charge (ATP + 0.5ADP/ATP + ADP + AMP). Eleven surgical patients with grade IV hepatic coma were treated by an ex vivo pig or baboon liver cross-hemodialysis with an interposed Cuprophan membrane when their blood ketone body ratios had decreased to below 0.4 compared with the normal of above 0.7. Three patients were treated by cross-hemodialysis using a standard Cuprophan membrane dialyzer without increase of blood ketone body ratio and without marked beneficial effect. However, five of eight patients who had blood ketone body ratios of above 0.25 became fully alert after treatment by cross-hemodialysis using the larger pore size and greater surface area Cuprophan membrane, concurrent with a rise in the decreased blood ketone body ratio, and three of them were later discharged. By contrast, in the three patients with blood ketone body ratios below 0.25, there was no restoration of consciousness and no improvement in their blood ketone body ratios by this liver support. It is suggested that, as long as the blood ketone body ratio remained over 0.25, this metabolic liver support is effective in restoring grade IV hepatic coma.
D000368:Aged; D000818:Animals; D001794:Blood Pressure; D006528:Carcinoma, Hepatocellular / Q000601:surgery; D005260:Female; D006501:Hepatic Encephalopathy / Q000628:therapy*; D006801:Humans; D007657:Ketone Bodies / Q000097:blood; D008103:Liver Cirrhosis / Q000601:surgery; D008113:Liver Neoplasms; D008297:Male; D008875:Middle Aged; D010215:Papio; D011183:Postoperative Complications; D006435:Renal Dialysis / Q000379:methods*; D013552:Swine
D007657:Ketone Bodies